Theratechnologies Inc. (THTX)
NASDAQ: THTX · Real-Time Price · USD
3.275
+0.005 (0.15%)
Sep 8, 2025, 10:52 AM - Market open
Theratechnologies Employees
Theratechnologies had 103 employees as of November 30, 2023. The number of employees decreased by 41 or -28.47% compared to the previous year.
Employees
103
Change (1Y)
-41
Growth (1Y)
-28.47%
Revenue / Employee
$819,204
Profits / Employee
-$88,903
Market Cap
150.58M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Nov 30, 2023 | 103 | -41 | -28.47% |
Nov 30, 2022 | 144 | 57 | 65.52% |
Nov 30, 2021 | 87 | 33 | 61.11% |
Nov 30, 2020 | 54 | 12 | 28.57% |
Nov 30, 2019 | 42 | 10 | 31.25% |
Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Nov 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
THTX News
- 3 days ago - Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy - GlobeNewsWire
- 6 days ago - Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak - GlobeNewsWire
- 21 days ago - Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak - GlobeNewsWire
- 2 months ago - Theratechnologies Reports Financial Results for the Second Quarter 2025 - GlobeNewsWire
- 2 months ago - Theratechnologies to Announce Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak - GlobeNewsWire
- 3 months ago - Theratechnologies Reports on its Annual Meeting of Shareholders - GlobeNewsWire
- 4 months ago - Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV - GlobeNewsWire